CossartYE, CantB, FieldAM, WiddowsD.Parvovirus-like particles in human sera. Lancet1975;1:72–73.
2.
AndersonMJ, JonesSE, Fisher-HochSP, Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet1983;1:1378.
3.
PattisonJR, JonesSE, HodgsonJ, Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet1981;1:664–665.
4.
YoungNS, MortimerPP, MooreJG, HumphriesRK. Characterization of a virus that causes transient aplastic crisis. J Clin Invest1984;73:224–230.
5.
CotmoreSF, TattersallP.Characterization and molecular cloning of a human parvovirus genome. Science1984;226:1161–1165.
6.
ShadeRO, BlundellMC, CotmoreSF, TattersallP, AstellCR. Nucleotide sequence and genome organization of human parvovirus 19 isolated from the serum of a child during aplastic crisis. J Virol1986;58:921–936.
7.
MoriJ, BeattieP, MeltonDW, CohenBJ, ClewleyJP. Structure and mapping of the DNA of human parvovirus B19. J Gen Virol1987;68:2797–2806.
8.
von dem BorneAEGK, BosMJE, Joustra-MaasN, TrompJF, van Wijngaarden-duBois R, TetterooPAT. A murine monoclonal IgM antibody specific for blood group P antigen (globoside). Br J Haematol1986;63:35–46.
9.
BrownKE, HibbsJR, GallinellaG, Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med1994;330:1192–1196.
10.
BrownKE, AndersonSM, YoungNS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science1993;262:114–117.
11.
KerrJR, McQuaidS, CoylePV. Expression of P antigen in parvovirus B19–infected bone marrow. N Engl J Med1995;332:128.
12.
OzawaK, KurtzmanG, YoungN.Replication of the B19 parvovirus in human bone marrow cell cultures. Science1986;233:883–886.
13.
PallierC, GrecoA, le JunterJ, SaibA, VassiusI, MorinetF.The 3' untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells. J Virol1997;71:9482–9489.
MoreyAL, FergusonDJP, LeslieKO, TaatjesDJ, FlemingKA. Intracellular localization of parvovirus B19 nucleic acid at the ultrastructural level by in situ hybridization with digoxigenin-labelled probes. Histochem J1993;25:421–429.
16.
MoffattS, YaegashiN, TadaK, TanakaN, SugamuraK.Human parvovirus B19 nonstructural (NSI) protein induces apoptosis in erythroid lineage cells. J Virol1998;72:3018–3028.
17.
TörökTJ. Human parvovirus B19. In: RemingtonJS, KleinJO, eds. Infectious Diseases of the Fetus and Newborn Infant, 4th ed. Philadelphia: W.B. Saunders, 1995;668–702.
18.
LunardiC, TisoA, BorgatoL, Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol1998;28:936–948.
19.
TakahashiM, ItoM, SakamotoF, Human parvovirus B19 infection: immunohistochemical and electron microscopic studies of skin lesions. J Cutan Pathol1995;22:168–172.
20.
CooperCL, ChoudhriSH. Answer to photo quiz II. Clin Infect Dis1998;26:989.
21.
CormanLC, DolsonDJ. Polyarteritis nodosa and parvovirus B19 infection. Lancet1992;339:491.
22.
AgerEA, ChinTDY, PolandJD. Epidemic erythema infectiosum. N Engl J Med1966;275:1326–1331.
23.
MusianiM, ZerbiniM, GentilomiG, PlazziM, GallinellaG, VenturoliS.Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis1995;172:1360–1363.
24.
MurrayJC, GresikMV, LegerF, McClainKL. B19 parvovirus–induced anemia in a normal child. Am J Pediatr Hematol Oncol1993;15:420–423.
25.
KurtzmanG, FrickhofenN, KimballJ, JenkinsDW, NienhuisAW, YoungNS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med1989;321:519–523.
26.
FadenH, GaryGW, AndersonLJ. Chronic parvovirus infection in a presumably immunologically healthy woman. Clin Infect Dis1992;15:595–597.
27.
SasakiT, MuraiC, MuryoiT, Persistent infection of human parvovirus B19 in a normal subject. Lancet1995; 346:851.
28.
ChambersLA, RauckAM. Acute transient hemolytic anemia with a positive Donath-Landsteiner test following parvovirus B19 infection. J Pediatr Hematol Oncol1996; 18:178–181.
29.
BertrandY, LefrereJJ, LevergerG, Autoimmune haemolytic anaemia revealed by human parvovirus linked erythroblastopenia. Lancet1985;2:382–383.
30.
SmithMA, ShahNS, LobelJS. Parvovirus B19 infection associated with reticulocytopenia and chronic autoimmune hemolytic anemia. Am J Pediatr Hematol Oncol1989;11:167–169.
AndersenLJ, TsouC, ParkerRA, Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol1986;24:522–526.
34.
ErdmanDD, UsherMJ, TsouC, Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol1991;35:110–115.
35.
SlootsT, DevinePL. Evaluation of four commercial enzyme immunoassays for detection of immunoglobulin M antibodies to human parvovirus B19. Eur J Clin Microbiol Infect Dis1996;15:758–761.
36.
KurtzmanGJ, CohenBJ, FieldAM, OseasR, BlaeseRM, YoungNS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest1989;84:1114–1123.
37.
YoungN, MortimerP.Viruses and bone marrow failure. Blood1984;63:729–737.
38.
RaoSP, MillerST, CohenBJ. Transient aplastic crisis in patients with sickle cell disease: B19 parvovirus studies during a 7-year period. Am J Dis Childhood1992;146:1328–1330.
39.
SaarinenUM, ChorbaTL, TattersallP, Human parvovirus B19–induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood1986;67:1411–1417.
40.
SerjeantGR, SerjeantBE, ThomasPW, AndersonMJ, PatouG, PattisonJR. Human parvovirus infection in homozygous sickle cell disease. Lancet1993;341:1237–1240.
41.
GossGA, SzerJ.Pancytopenia following infection with human parvovirus B19 as a presenting feature of hereditary spherocytosis in two siblings. Aust NZ J Med1997;27:86–87.
42.
LudmererKM, KissaneJM, eds. Clinicopathologic Conference. Am J Med1998;104:200–209.
43.
LowenthalEA, PrchalJT. Parvovirus B19 induced red blood cell aplasia in a patient with hereditary pyropoikilocytosis. Blood1995;86:411–412.
44.
MallouhAA, QudahA.Acute splenic sequestration together with aplastic crisis caused by human parvovirus B19 in patients with sickle cell disease. J Pediatr1993;122:593–595.
45.
LowenthalEA, WellsA, EmanuelPD, PlayerR, PrchalJT. Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review. Am J Hematol1996;51:207–213.
46.
GoldsteinLJ, StrengerR, KingTC, LeSC, RogersBB. Retrospective diagnosis of sickle cell-hemoglobin C disease and parvovirus infection by molecular DNA analysis of postmortem tissue. Hum Pathol1995;26:1375–1378.
47.
KolquistKA, Vnencak-JonesCL, SwiftL, PageDL, JohnsonJE, DenisonMR. Fatal fat embolism syndrome in a child with undiagnosed hemoglobin S/β+ thalassemia: a complication of acute parvovirus B19 infection. Pediatr Pathol Lab Med1996;16:71–82.
48.
Van HornDK, MortimerPP, YoungN, HansonGR. Human parvovirus-associated red cell aplasia in the absence of underlying hemolytic anemia. Am J Pediatr Hematol Oncol1986;8:235–239.
49.
YotoYKudohTSuzukiN, MatsunagaYChibaS.Retrospective study on the influence of human parvovirus B19 infection among children with malignant diseases. Acta Haematol1993;90:8–12.
50.
RaoSP, MillerST, CohenBJ. Severe anemia due to B19 parvovirus infection in children with acute leukemia in remission. Am J Pediatr Hematol Oncol1990;12:194–197.
51.
CarstensenH, ØmvoldK, CohenBJ. Human parvovirus B19 infection associated with prolonged erythroblastopeniaina leukemic child. Pediatr Infect Dis J1989;8:56.
52.
FisherD, SpencerD, IlandH, BrammahS, CossartY.Red cell aplasia caused by human parvovirus B19 in acute leukaemia. Aust NZ J Med1992;22:303–304.
53.
SmithMA, ShahNR, LobelJS, CeraPJ, GaryGW, AndersonLJ. Severe anemia caused by human parvovirus in a leukemia patient on maintenance chemotherapy. Clin Pediatr1988;27:383–386.
54.
CoulombelL, MorinetF, MielotF, TcherniaG.Parvovirus infection, leukaemia, and immunodeficiency. Lancet1989; 1:101–102.
55.
KurtzmanGJ, CohenB, MeyersPAminullahA, YoungNS. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet1988;2:1159–1162.
56.
WeilandHT, SalimansMMM, FibbeWE, KluinPM, CohenBJ. Prolonged parvovirus B19 infection with severe anemia in a bone marrow transplant recipient. Br J Haematol1989;71:300.
BertoniE, RosatiA, ZanazziM, Severe aplastic anaemia due to B19 parvovirus infection in renal transplant recipient. Nephrol Dial Transplant1995;10:1462–1463.
59.
ChangFY, SinghN, GayowskiT, MarinoIR. Parvovirus B19 infection in a liver transplant recipient: case report and review in organ transplant recipients. Clin Transplant1996;10:243–247.
60.
FrickhofenN, AbkowitzJL, SaffordM, Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type I (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med1990;113:926–933.
61.
GriffinTC, SquiresJE, TimmonsCF, BuchananGR. Chronic human parvovirus B19-induced erythroid hypoplasia as the initial manifestation of human immunodeficiency virus infection. J Pediatr1991;118:899–901.
62.
ChernakE, DubinG, HenryD, Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis1995;20:170–173.
63.
van Elsacker-NieleAMW, KroonFP, van der EndeME, SalimansMMM, SpaanWJM, KroesACM. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus. Clin Infect Dis1996;23:1255–1260.
64.
NelsonAM, AbbondanzoSL, FortunatoRA, SunYC, ShiehW-J, ZakiSR. Parvovirus B19 as a cause of anemia in human immunodeficiency virus (HIV) infected patients. Mod Pathol1996;9:131A.
65.
ZakrzewskaK, AzziA, PatouG, MorfiniM, RafanelliD, PattisonJR. Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction. Br J Haematol1992;81:407–412.
66.
SantagostinoE, MannucciPM, GringeriA, Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100°C heat after lyophilization. Transfusion1997;37:517–522.
67.
LyonDJ, ChapmanCS, MartinC, Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate. Lancet1989;1:1085.
68.
MorfiniM, LongoG, RossiFerrini PLetter to the Editor: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: the role of human B19 parvovirus. Am J Hematol1992;39:149–150.
69.
NagaiK, MorohoshiT, KudohT, YotoYSuzukiN, MatsunagaY.Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection. Br J Haematol1992;80:131–132.
70.
HanadaT, KoikeK, HiranoC, Childhood transient erythroblastopenia complicated by thrombocytopenia and neutropenia. Eur J Haematol1989;42:77–80.
71.
WodzinskiMA, LilleymanJS. Transient erythroblastopenia of childhood due to human parvovirus B19 infection. Br J Haematol1989;73:127–131.
72.
BhambhaniK, InoueS, SarnaikSA, MerlineJ.Transient erythroblastopenia of childhood not associated with human parvovirus infection. Lancet1986;1:509.
73.
RogersBB, RogersZR, TimmonsCF. Polymerase chain reaction amplification of archival material for parvovirus B19 in children with transient erythroblastopenia of childhood. Pediatr Pathol Lab Med1996;16:471–478.
74.
YotoY, KudohT, SuzukiN, KatohS, MatsunagaY, ChibaS.Thrombocytopenia induced by human parvovirus B19 infections. Eur J Haematol1993;50:255–257.
75.
OedaE, ShinoharaK, InoueH, NomiyamaJ.Parovovirus B19 infection causing severe peripheral blood thrombocytopenia and persistent viremia. Am J Hematol1994;45:274–275.
76.
AssyN, RosenthalE, HazaniA, EtzioniA, BaruchY.Human parvovirus B19 infection associated with idiopathic thrombocytopenia purpura in a child following liver transplantation. J Hepatol1997;27:934–936.
77.
MurrayJC, KelleyPK, HogrefeWR, McClainKL. Childhood idiopathic thrombocytopenic purpura: association with human parvovirus B19 infection. Am J Pediatr Hematol Oncol1994;16:314–319.
78.
van Elsacker-NieleA-MW, WeilandHT, KroesACM, Kappers-KlunneMC. Parvovirus B19 infection and idiopathic thrombocytopenia purpura. Ann Hematol1996;72:141–144.
HoangMP, DawsonDB, RogersZR, ScheuermannRH, RogersBB. Polymerase chain reaction amplification of archival material for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, and parvovirus B19 in children with bone marrow hemophagocytosis. Hum Pathol1998; 29:1074–1077.
84.
SalimansMMM, HolsappelS, van de RijkeFM, JiwaNM, RaapAK, WeilandHT. Rapid detection of human parvovirus B19 DNA by dot-hybridization and the polymerase chain reaction. J Virol Methods1989;23:19–28.
85.
BurtonPA. Intranuclear inclusions in marrow of hydropic fetus due to parvovirus infection. Lancet1986;2:1155.
TaillanB, HeudierP, FerrariE, GarnierG, FuzibetJ-G, DujardinP.Pure red-cell aplasia due to parvovirus B19 infection in a patient with AIDS-related complex. Ann Med1992;24:137.
88.
GahrM, PekrunA, EiffertH.Persistence of parvovirus B19-DNA in blood of a child with severe combined immunodeficiency associated with chronic pure red cell aplasia. Eur J Pediatr1991;150:470–472.
89.
KoduriPR. Novel cytomorphology of the giant pronormoblasts of parvovirus B19 infection. Am J Hematol1998;58:95–99.
90.
LiuW, IttmannM, LiuJ, Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: a comparative study using “in situ” hybridization and immunohistochemistry. Hum Pathol1997;28:760–766.
91.
Skjöldebrand-SparreL, FridellE, NymanM, WahrenB.A prospective study of antibodies against parvovirus B19 in pregnancy. Acta Obstet Gynecol Scand1996;75:336–339.
92.
GuidozziF, BallotD, RothbergAD. Human B19 parvovirus infection in an obstetric population. J Reprod Med1994;39:36–38.
93.
GratacósE, TorresP-J, VidalJ, The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis1995;171:1360–1363.
94.
SchwarzTF, RoggendorfM, HottenträgerB, Human parvovirus B19 infection in pregnancy. Lancet1988;2:566–567.
95.
HargerJH, AdlerSP, KochWC, HargerGF. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol1998;91:413–420.
96.
SchwarzTF, NerlichA, HottenträgerB, Parvovirus B19 infection of the fetus. Am J Clin Pathol1991;96:121–126.
97.
SallerDN, RogersBB, CanickJA. Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection. Prenat Diag1993;13:467–471.
98.
PetrikovskyBM, BakerD, SchneiderE.Fetal hydrops secondary to human parvovirus infection in early pregnancy. Prenat Diagn1996;16:342–344.
99.
ChorbaT, CocciaP, HolmanRC, The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis1986;154:383–393.
100.
RaySM, ErdmanDD, BerschlingJD, CooperJE, TörökTJ, BlumbergHM. Nosocomial exposure to parvovirus B19: low risk of transmission to healthcare workers. Infect Control Hosp Epidemiol1997;18:109–114.
101.
BellLM, NaidesSJ, StoffmanP, HodinkaRL, PlotkinSA. Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med1989;321:485–491.
102.
CarringtonD, GilmoreDH, WhittleMJ, Maternal serum alpha fetoprotein—a marker of fetal aplastic crisis during intrauterine human parvovirus infection. Lancet1987;1:433–435.
103.
BernsteinIM, CapelessEL. Elevated maternal serum alpha-fetoprotein and hydrops fetalis in association with fetal parvovirus B-19 infection. Obstet Gynecol1989;74:456–457.
104.
KomischkeK, SearleK, EndersG.Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnant women with acute parvovirus B19 infection with and without complications. Prenat Diagn1997;17:1039–1046.
105.
JohnsonDR, FisherRA, HelwickJJ, MurrayDL, PattersonMJ, DownesFP. Screening maternal serum alpha-fetoprotein levels and human parvovirus antibodies. Prenat Diagn1994;14:455–458.
106.
Public Health Laboratory Service Working Party on Fifth Disease.Prospective study of human parvovirus (B19) infection in pregnancy. BMJ1990;300:1166–1170.
107.
RodisJF, QuinnDL, GaryGW, Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol1990;163:1168–1171.
AnandA, GrayES, BrownT, ClewleyJP, CohenBJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med1987;316:183–186.
110.
RogersBB, MarkY, OyerCE. Diagnosis and incidence of fetal parvovirus infection in an autopsy series: I. Histology. Pediatr Pathol1993;13:371–379.
111.
RodisJF, RodnerC, HansenAA, BorgidaAF, DeoliveiraI, RosengrenSS. Long-term outcome of children following maternal human parvovirus B19 infection. Obstet Gynecol1998;91:125–128.
112.
BrownKE, GreenSW, de MayoloJA, Congenital anemia after transplacental B19 parvovirus infection. Lancet1994;343:895–896.
113.
DondersGGG, Van LierdeS, van Elsacker-NieleAMW, MoermanP, GoubauP, VandenbergheK.Survival after intrauterine parvovirus B19 infection with persistence in early infancy: a two-year follow-up. Pediatr Infect Dis J1994;13:234–236.
HartwigNG, Vermeij-KeersC, van Elsacker-NieleAMW, FleurenGJ. Embryonic malformations in a case of intrauterine parvovirus B19 infection. Teratology1989;39:295–302.
116.
TiessenRG, van Elsacker-NieleAMW, Vermeij-KeersC, OepkesD, Van RoosmalenJ, GorsiraMCB. A fetus with a parvovirus B19 infection and congenital anomalies. Prenat Diagn1994;14:173–176.
117.
WhiteFV, JordanJ, DickmanPS, KniselyAS. Fetal parvovirus B19 infection and liver disease of antenatal onset in an infant with Ebstein's anomaly. Pediatr Pathol Lab Med1995;15:121–129.
118.
BartonLL, LaxD, ShehabZM, KeithJC. Congenital cardiomyopathy associated with human parvovirus B19 infection. Am Heart J1997;133:131–133.
119.
MarkY, RogersBB, OyerCE. Diagnosis and incidence of fetal parvovirus infection in an autopsy series: II. DNA amplification. Pediatr Pathol1993;13:381–386.
120.
RogersBB. Case 5. Histopathologic variability of finding erythroid inclusions with intrauterine parvovirus B19 infection. Pediatr Pathol1992;12:883–889.
121.
FranciosiRA, TattersallP.Fetal infection with human parvovirus B19. Hum Pathol1988;19:489–491.
122.
FieldAM, CohenBJ, BrownKE, Detection of B19 parvovirus in human fetal tissues by electron microscopy. J Med Virol1991;35:85–95.
123.
KniselyAS, O'SheaPA, McMillanP, SingerDB, MagidMS. Electron microscopic identification of parvovirus virions in erythroid-line cells in fatal hydrops fetalis. Pediatr Pathol1988;8:163–170.
124.
CaulEO, UsherMJ, BurtonPA. Intrauterine infection with human parvovirus B19: a light and electron microscopy study. J Med Virol1988;24:55–66.
125.
NascimentoJP, HallamNF, MoriJ, Detection of B19 parvovirus in human fetal tissues by in situ hybridisation. J Med Virol1991;33:77–82.
126.
SalimansMMM, van de RijkeFM, RaapAK, van Elsacker-NieleAMW. Detection of parvovirus B19 DNA in fetal tissues by in situ hybridisation and polymerase chain reaction. J Clin Pathol1989;42:525–530.
127.
PorterHJ, HeryetA, QuantrillAM, FlemingKA. Combined non-isotopic in situ hybridisation and immunohistochemistry on routine paraffin wax embedded tissue: identification of cell type infected by human parvovirus and demonstration of cytomegalovirus DNA and antigen in renal infection. J Clin Pathol1990;43:129–132.
128.
PilavdzicD, LinesLD, PetricM, SilverMM. Immunoelectron microscopic identification of human parvovirus B19. Ultrastruct Pathol1994;18:417–422.
129.
van Elsacker-NieleAMW, SalimansMMM, WeilandHT, Vermey-KeersC, AndersonMJ, VersteegJ.Fetal pathology in human parvovirus B19 infection. Br J Obstet Gynaecol1989;96:768–775.
130.
PorterHJ, QuantrillAM, FlemingKA. B19 parvovirus infection of myocardial cells. Lancet1988;2:535–536.
131.
WrightC, HinchliffeSA, TaylorC.Fetal pathology in intrauterine death due to parvovirus B19 infection. Br J Obstet Gynaecol1996;103:133–136.
RogersBB, SingerDB, MakSK, GaryGW, FikrigMK, McMillanPN. Detection of human parvovirus B19 in early spontaneous abortuses using serology, histology, electron microscopy, in situ hybridization, and the polymerase chain reaction. Obstet Gynecol1993;81:402–408.
134.
SahakianV, WeinerCP, NaidesSJ, WilliamsonRA, ScharoschLL. Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Am J Obstet Gynecol1991;164:1090–1091.
135.
NikkariS, EkbladU.A rapid and safe method to detect fetal parvovirus B19 infection in amniotic fluid by polymerase chain reaction: report of a case. Am J Perinatol1995;12:447–449.
136.
PetersMT, NicolaidesKH. Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection. Obstet Gynecol1990;75:501–504.
137.
ZerbiniM, MusianiM, GentilomiG, VenturoliS, GallinellaG, MorandiR.Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops. J Clin Microbiol1996;34:603–608.
138.
TörökTJ, WangQ-Y, GaryGW, YangC-F, FinchTM, AndersonLJ. Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique. Clin Infect Dis1992;14:149–155.
139.
GentilomiG, ZerbiniM, GallinellaG, B19 parvovirus induced fetal hydrops: rapid and simple diagnosis by detection of B19 antigens in amniotic fluids. Prenat Diagn1998;18:363–368.
140.
WoolfAD, CohenBJ. Parvovirus B19 and chronic arthritis—causal or casual association? Am Rheum Dis1995;54:535–536.
141.
NoctonJJ, MillerLC, TuckerLB, SchallerJG. Human parvovirus B19–associated arthritis in children. J Pediatr1993;122:186–190.
142.
SöderlundM, von EssenR, HaapasaariJ, KiistalaU, KiviluotoO, HedmanK.Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet1997;349:1063–1065.
143.
KerrJR, BoydN.Autoantibodies following parvovirus B19 infection. J Infect1996;32:41–47.
144.
RogersBB. Nucleic acid amplification and infectious disease. Hum Pathol1994;25:591–593.
145.
SchowengerdtKO, NiJ, DenfieldSW, Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection. Circulation1997;96:3549–3554.
146.
OkumuraA, IchikawaT.Aseptic meningitis caused by human parvovirus B19. Arch Dis Child1993;68:784–785.
HaseyamaK, KudohT, YotoY, SuzukiN, ChibaS.Detection of human parvovirus B19 DNA in cerebrospinal fluid. Pediatr Infect Dis J1997;16:324–326.
149.
CassinottiP, SchultzeD, SchlageterP, CheviliS, SieglG.Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient. Eur J Clin Microbiol Infect Dis1993;12:701–704.
150.
HeegaardED, PeterslundNA, HornslethA.Parvovirus B19 infection associated with encephalitis in a patient suffering from malignant lymphoma. Scand J Infect Dis1995;27:631–633.
151.
MetzmanR, AnandA, DeGiulioPA, KniselyAS. Hepatic disease associated with intrauterine parvovirus B19 infection in a newborn premature infant. J Pediatr Gastroenterol Nutr1989;9:112–114.